Samrat Pharmachem Ltd
Ticker: SAMRATPH
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
289.25
Market Cap
89.37
Debt/Equity
0.1380
ROE %
10.409
PB
1.2447
Promoter %
49.091
Pledge %
0.000
1Y Rev Growth %
1.368
5Y Rev Growth %
15.752
NP Margin %
2.482
NP Margin 5Y Avg %
3.859
Trading Reference
1M Return %
-9.575
6M Return %
-12.095
1Y Return %
-45.980
% Away 52W High
97.061
% Away 52W Low
1.456
Daily Volume
1277
Investment Verdict
Buy
Score 77/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Samrat Pharmachem Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above the resistance at 150. Volume has been increasing, suggesting bullish sentiment. However, if it fails to hold the support at 130, there could be a downside risk.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Aakash Exploration Services Ltd
Aakash Exploration Services Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment. Caution is advised.
View details
P
Parmeshwar Metal Ltd
Parmeshwar Metal Ltd presents a mixed outlook with several risks that could impact future performance.
View details
A
ANI Integrated Services Ltd
ANI Integrated Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hisar Metal Industries Ltd
Hisar Metal Industries Ltd shows moderate potential but faces challenges in growth and profitability metrics.
View details
S
Softrak Venture Investment Ltd
Softrak Venture Investment Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
A
Acme Resources Ltd
Acme Resources Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and market sentiment.
View details
C
Citizen Infoline Ltd
Citizen Infoline Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rajnish Wellness Ltd
Rajnish Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
BITS Ltd
BITS Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
C
Cinevista Ltd
Cinevista Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vikram Kamats Hospitality Ltd
Vikram Kamats Hospitality Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sharp Chucks and Machines Ltd
The company operates in a promising sector, but inconsistent financial performance and governance issues raise concerns.
View details
A
AKI India Ltd
AKI India Ltd shows potential but faces several challenges that may hinder its growth and profitability.
View details
P
Polychem Ltd
Polychem Ltd shows several weaknesses in growth consistency and market sentiment, making it a risky investment.
View details
S
Sel Manufacturing Company Ltd
The stock shows potential but is hindered by inconsistent growth and market risks.
View details
P
Paramatrix Technologies Ltd
Paramatrix Technologies Ltd shows potential but faces several challenges that could impact its growth and profitability.
View details
Business Overview
Samrat Pharmachem Ltd is a leading player in the Indian pharmaceutical industry, specializing in the production of high-quality chemicals and intermediates. Catering to both domestic and international markets, the company supports various sectors, including pharmaceuticals, agrochemicals, and specialty chemicals. With a commitment to innovation and sustainability, Samrat Pharmachem is poised for growth, making it a reliable choice for investors and partners alike.
- Established leader in the pharmaceutical sector
- Focus on high-quality chemicals and intermediates
- Serves diverse industries including pharmaceuticals and agrochemicals
- Strong commitment to innovation and sustainability
- Robust growth potential in domestic and international markets
Investment Thesis
Samrat Pharmachem Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and long-term value creation, making it a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record in the pharmaceutical sector.
- Significant growth potential in digital services, enhancing operational efficiency.
- Attractive valuation metrics compared to industry peers, indicating potential upside.
- Focus on innovation and product development to capture market share.
- Strategic positioning to benefit from increasing healthcare demands in India.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong product pipeline
- Government support for healthcare
- Rising healthcare awareness among consumers
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependency on key suppliers
- Fluctuating raw material costs
Peer Perspective
Samrat Pharmachem Ltd trades at a discount to peers like Aarti Drugs and Granules India, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Samrat Pharmachem Ltd is well-positioned for growth, driven by increasing demand in the pharmaceutical sector. However, successful execution of expansion plans and stringent cost control will be crucial for maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Samrat Pharmachem Ltd do?A: Samrat Pharmachem Ltd is involved in manufacturing and distributing pharmaceutical and chemical products.
- Q: Is Samrat Pharmachem Ltd a profitable company?A: Profitability can vary; check the latest financial reports for current performance details.
- Q: What are the risks of investing in Samrat Pharmachem Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Samrat Pharmachem Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Samrat Pharmachem Ltd?A: You can find information in financial news, the company's website, and stock market reports.
📊 Stock Investment Checklist (100 Points)
Samrat Pharmachem Ltd • Updated: 2025-09-17 16:29:39
-
10BusinessHighPharmaceutical sector is growing, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, cash flow is stable.
-
8ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some pledging issues.
-
5DriversGoodLimited growth drivers identified, execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100